Canada has approved its first generic semaglutide injection, potentially lowering costs and easing shortages of the blockbuster diabetes and weight-loss drug. The move comes as new studies raise ...

Health Canada has granted Dr. Reddy’s Laboratories a Notice of Compliance for a generic version of semaglutide injection, ...

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines ​unless they appear ...

Prescribing smaller GLP-1 receptor agonist doses could help users tolerate the drugs and lead to a more patient-centered ...

Slimpic has emerged in 2026 as one of the most discussed natural weight management formulas in the prebiotic and probiotic ...

In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, which is the ...

Widespread use of generic GLP-1 medications could help Ontario residents save money and lose weight while forcing the food ...

Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.

These negative comments about bodies and faces permeate society and could lead to some tough talks with friends ...

Novo Nordisk bets on oral Ozempic launch and pediatric label expansions to counter slowing demand, pricing pressure and ...

Many people are turning to lower doses of weight loss drugs—but there’s little evidence on whether the approach is actually ...